GlassScriptPhysician profile
Alexander D Minard
NPI 1750383337
$3,049.68
in general payments reported to CMS, 2019-2025
19 companies · $715 in 2025
The $715 reported for 2025 was more than what 84% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $221 · 2020: $234 · 2021: $128 · 2022: $566 · 2023: $575 · 2024: $610 · 2025: $715.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,901.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,900.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,058.65 | 2022-2025 | |
| Merz Pharmaceuticals, LLC | $415.68 | 2021-2025 | Xeomin |
| Allergan, INC. | $285.37 | 2019-2022 | |
| Amgen INC. | $182.09 | 2021-2022 | |
| Lundbeck LLC | $180.60 | 2024-2025 | Vyepti |
| Pfizer INC. | $157.27 | 2023-2025 | |
| Boston Scientific Corporation | $145.53 | 2025 | Intracept |
| Lilly USA, LLC | $141.60 | 2019-2024 | Emgality, Reyvow |
| Teva Pharmaceuticals USA, INC. | $126.41 | 2019-2025 | Ajovy |
| Merz North America, INC. | $95.72 | 2019-2020 | |
| Abbott Laboratories | $45.04 | 2020-2021 | |
| Axsome Therapeutics, INC. | $43.04 | 2025 | Symbravo |
| Biohaven Pharmaceutical Holding Company LTD. | $42.43 | 2022 | |
| Averitas Pharma INC. | $33.58 | 2023-2025 | Qutenza |
| Tonix Medicines, INC. | $31.88 | 2025 | Tonmya |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grt US Holding, INC. | $20.12 | 2022 | |
| Bioventus LLC | $18.17 | 2024 | Durolane |
| Impel Pharmaceuticals INC. | $14.10 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $12.40 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Minard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.